CW · Curtiss Wright Corp · Insider Trading

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.

The reporting person contributed Issuer common stock ("Common Stock") to an exchange fund in exchange for shares of the exchange fund. For purposes of determining the number of shares of the exchange fund issuable pursuant to such exchange, the Common Stock was valued at $619.46 per share, which was the closing price of the Common Stock on the New York Stock Exchange on August 26, 2026. The transaction with the exchange fund closed on August 27, 2025.

Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP"), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).

In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.

Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP"), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).

In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.

Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP"), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).

In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.

Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP"), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).

In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.

Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP"), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).

In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.

Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2026 and maintained by the Reporting Person's financial advisor.

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.

Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on March 10, 2026 and maintained by the Reporting Person's financial advisor.

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $754.05 to $766.75, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on March 10, 2026 and maintained by the Reporting Person's financial advisor.

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $705.34 to $736.99, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on March 10, 2026 and maintained by the Reporting Person's financial advisor

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $703.54 to $739.63, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to defer their compensation, including their annual restricted stock award, and/or receive their annual retainer and meeting fees in the form of stock at a later date.

Reflects the annual restricted stock award that was earned in 2021, but receipt was deferred to June 1, 2025. Number of shares acquired is calculated based on the value of the award ($125,000) divided by the closing price of $115.24 for the Issuer's common stock as reported by the New York Stock Exchange on February 16, 2021, the date the Board initially approved the award. The number of shares is rounded up to the nearest whole share and includes dividend credits earned on outstanding award. This amount reflects 20% of the Reporting Person's restricted stock award as the reporting person elected to receive the restricted stock in five equal installments beginning June 1, 2025.

Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of June 1, 2026. The date recipient elected to receive his shares.

Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to receive their annual retainer, committee chair, and meeting fees in the form of stock.

Number of shares is calculated by taking the amount of the Reporting Person's earned retainer and dividing that amount by the closing price of the Issuer's common stock on the date such retainer was earned.

Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of May 29, 2026. The date recipient elected to receive her shares.

Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2026 and maintained by the Reporting Person's financial advisor.

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.

Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to defer receipt of their annual restricted stock award to a later date.

Number of shares acquired is calculated based on the value of the award ($125,000) divided by the closing price of $115.24 for the Issuer's common stock as reported by the New York Stock Exchange on February 16, 2021, the date the Board initially approved the award. The number of shares is rounded up to the nearest whole share and includes dividend credits earned on outstanding award. This amount reflects 20% of the reporting person's restricted stock award as the reporting person elected to receive the restricted stock award in five equal annual installments beginning May 12, 2024.

Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of May 12, 2026. The date reporting person elected to receive her shares.

Shares were issued pursuant to the Company's 2024 Omnibus Incentive Plan in which newly elected non-employee directors receive an initial grant of restricted stock in the amount of $35,000 for service on the board. The restrictions on these shares lapse upon the shorter of (a) five years from the date of grant or (b) until such time as the service of the recipient as a non-employee director of the Company shall have ended by reason of his or her (i) death or disability or (ii) failure to be reelected.

The number of shares calculated is based on the value of the award ($35,000.00) divided by the closing price of $724.43 for Issuer's common stock as reported by the New York Stock Exchange on May 7, 2026, the date the reporting person was elected to the Board of Directors.

Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2025 and maintained by the Reporting Person's financial advisor.

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $681.18 to $699.31, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2025 and maintained by the Reporting Person's financial advisor.

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $682.74 to $698.09, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.53 to $681.02, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $669.72 to $681.43, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.53 to $681.02, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.52 to $681, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.23 to $681.66, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $669.05 to $681, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.25 to $681.02, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

Share total includes dividend credits earned on prior outstanding grants.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

Share total includes dividend credits earned on prior outstanding grants.

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

Share total includes dividend credits earned on prior outstanding grants.

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

Share total includes dividend credits earned on prior outstanding grants.

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

Share total includes dividend credits earned on prior outstanding grants.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

Share total includes dividend credits earned on prior outstanding grants.

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

Share total includes dividend credits earned on prior outstanding grants.

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

This is a time-based restricted stock unit ("RSU") grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

Share total includes dividend credits earned on prior outstanding grants.

This is a time-based restricted stock unit ("RSU") grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

Share total includes dividend credits earned on prior outstanding grants.

This is a time-based restricted stock unit ("RSU") grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

Share total includes dividend credits earned on prior outstanding grants.

This is a time-based restricted stock unit ("RSU") grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

Share total includes dividend credits earned on prior outstanding grants.

This is a time-based restricted stock unit ("RSU") grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

Share total includes dividend credits earned on prior outstanding grants.

This is a time-based restricted stock unit ("RSU") grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

Share total includes dividend credits earned on prior outstanding grants.

This is a time-based restricted stock unit ("RSU") grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

Share total includes dividend credits earned on prior outstanding grants.

Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on November 10, 2025 and maintained by the Reporting Person's financial advisor.

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $687.55 to $703.23, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on September 11, 2025 and maintained by the Reporting Person's financial advisor.

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $615.26 to $629.96, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Shares were issued pursuant to the Company's 2024 Omnibus Incentive Plan in which non-employee directors receive an annual grant of restricted stock for service on the board. The restrictions on these shares lapse upon the shorter of (a) one year from the date of grant or (b) until such time as the service of the recipient as a non-employee Director of the Company shall have ended by reason of his or her (i) death or disability or (ii) failure to be reelected.

The number of shares is arrived by dividing the closing price of the Issuer's securities on February 4, 2026 into $160,000, the amount of the stock award granted to the Issuer's non-employee directors. The number of shares is rounded down to the nearest whole share. This amount reflects 50% of the reporting person's annual restricted stock award. The reporting person has elected to defer receipt of the remaining 50% (i.e., 128 shares) of his annual restricted stock award to a later date.

Price is based on the close price for the Registrant's common stock on February 4, 2026, the date the reporting person earned the annual award.